Tracing the Metabolic Flux of Orally Administered NAD+ Precursors
Clinical trial NCT06882096 · RECRUITING
Trial details
- NCT number
- NCT06882096
- Sponsor
- Metro International Biotech, LLC
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-28
- Primary completion
- 2026-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.